We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.61B
AUM Growth
+$447M
Cap. Flow
+$533M
Cap. Flow %
33.15%
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$39.8M
2
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$32.6M
3
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$28.3M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$23.1M
5
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$19.9M

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$4.13M
2
NVDA icon
NVIDIA
NVDA
+$4.12M
3
PFE icon
Pfizer
PFE
+$4.01M
4
LNG icon
Cheniere Energy
LNG
+$3.83M
5
HOLX
Hologic
HOLX
+$3.1M

Sector Composition

Rank Sector Weight
1 Financials 13.44%
2 Technology 13.16%
3 Healthcare 12.56%
4 Industrials 12.44%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRVO icon
1801
CervoMed
CRVO
$24.6M
– –
-26,431
Closed -$209K
CRVS icon
1802
Corvus Pharmaceuticals
CRVS
$1.09B
– –
-14,188
Closed -$109K
CSBR icon
1803
Champions Oncology
CSBR
$84.2M
– –
-20,978
Closed -$145K
CSWC icon
1804
Capital Southwest
CSWC
$1.46B
– –
-22,564
Closed -$500K
CSX icon
1805
CSX Corp
CSX
$96B
– –
-26,738
Closed -$969K
CTSO icon
1806
Cytosorbents Corp
CTSO
$22.6M
– –
-148,374
Closed -$95K
CVAC
1807
DELISTED
CureVac
CVAC
– –
-10,744
Closed -$49K
CVGW
1808
DELISTED
Calavo Growers
CVGW
– –
-41,152
Closed -$895K
CVI icon
1809
CVR Energy
CVI
$3.43B
– –
-51,991
Closed -$1.32M
CVX icon
1810
Chevron
CVX
$378B
– –
-5,962
Closed -$909K
CYH icon
1811
Community Health Systems
CYH
$383M
– –
-143,779
Closed -$449K
CZR icon
1812
Caesars Entertainment
CZR
$6.1B
– –
-29,728
Closed -$695K
DAWN
1813
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-142,809
Closed -$1.33M
DBRG icon
1814
DigitalBridge
DBRG
$2.93B
– –
-35,813
Closed -$549K
DDOG icon
1815
Datadog
DDOG
$89.7B
– –
-4,059
Closed -$552K
KUST
1816
Kustom Entertainment Inc
KUST
$721K
– –
-1,345
Closed -$13K
DHX icon
1817
DHI Group
DHX
$164M
– –
-13,981
Closed -$22K
DLB icon
1818
Dolby
DLB
$4.85B
– –
-23,096
Closed -$1.48M
DMRC icon
1819
Digimarc Corp
DMRC
$137M
– –
-67,433
Closed -$442K
DNTH icon
1820
Dianthus Therapeutics
DNTH
$5.71B
– –
-9,715
Closed -$400K
DOW icon
1821
Dow Inc
DOW
$20.8B
– –
-8,859
Closed -$207K
DTIL icon
1822
Precision BioSciences
DTIL
$187M
– –
-38,767
Closed -$161K
DUK icon
1823
Duke Energy
DUK
$100B
– –
-2,324
Closed -$272K
DVA icon
1824
DaVita
DVA
$15.2B
– –
-6,680
Closed -$759K
DVAX
1825
DELISTED
Dynavax Technologies
DVAX
– –
-43,385
Closed -$667K
71 72
73
74 75

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

GSA Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
  • GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
  • GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
  • GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
  • GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.